Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

'Arms-for-food deal'
Mark Russell dies
Aniston on 'Friends'
Concealed guns permit
Finland to join NATO
Ford hikes prices
LFO member dies at 47
Trans rights protests
Ratings plummet 61%
May return to Pacific
Consider obesity drugs
Blocks DeSantis' power
Declares NBA draft
Plants make some noise
E3 cancels 2023 event
Removes over 5k tweets
Chinese hacking group
Ridley-Thomas guilty
Lips like a lizard?
Bam Margera arrested
Alleged victim's texts
'Abortion trafficking'
Ky. sports betting
COVID shots for kids
Soaring home run
Jetson tech recalled
OK's 4% tuition hike
Evacuation lifted
Mets' Opening Day win
2017 Vegas shooting
Makes solo debut
$2B loan to Pakistan
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
16,400 results
sfvbj4d
Amgen to Lay Off 450, Citing Inflation, Prices
Tech: Amgen scientists work at the company’s Thousand Oaks headquarters. Thousand Oaks-based pharma giant Amgen Inc. said it would lay off approximately 450 employees, or nearly 2% of its workforce, ...
Becker's Hospital Review13d
Amgen to lay off 450
Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26, according to a statement shared with Becker's. "We ...
The Acorn7d
Round two of job layoffs at Amgen
Amgen is laying off more workers in Ventura County. The bio-pharmaceutical giant said March 16 that it will eliminate about 450 jobs, or less than 2% of its global workforce. That’s on top of 305 cuts ...
1don MSN
Amgen Options Traders Betting On Stock Rising This Much By April Expiration
Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.
3d
Justices Debate Antibodies in Amgen-Sanofi Drug Patent Fight (1)
The Supreme Court appeared to struggle Monday over Amgen Inc.'s arguments in a dispute with Sanofi S.A. that two canceled ...
Benzinga.com2d
Amgen Deadline Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amgen To Contact Him Directly To Discuss Their Options New York, New York ...
Reuters3d
Amgen-Sanofi patent case divides makers of antibody drugs
March 27 (Reuters) - Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ...
4don MSN
Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court
The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a "blatant attempt" to ...
Wall Street Journal4d
Amgen Seeks to Monopolize Nature
On Monday the Supreme Court will hear oral arguments in Amgen v. Sanofi, a case with immense potential consequences for scientific innovation. If the high court upends settled patent law by ...
Seeking Alpha7d
Amgen: Questioning The Horizon Therapeutics Acquisition
Amgen reported solid results for fiscal 2022 with the bottom line growing in the double digits. The company recently announced the acquisition of Horizon Therapeutics and while the acquisition ...
sfvbj
4d
Fewer, But Larger, Local Bioscience Funding Deals
Fewer local bioscience and digital health firms received funding over the last couple of years than in previous years, but ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback